Stephanie Harris
Research Triangle Park Foundation(US)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery, Respiratory Support and Mechanisms, Pediatric health and respiratory diseases
Most-Cited Works
- → Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease(2017)571 cited
- → Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials(2014)233 cited
- → Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO(2021)73 cited
- → Relationship Between Carbamoyl-Phosphate Synthetase Genotype and Systemic Vascular Function(2004)67 cited
- → Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients(2012)54 cited
- → The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors(2008)43 cited
- → Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials(2016)9 cited
- → Efficacy and safety of the long‐acting muscarinic antagonist GSK233705 delivered once daily in patients with COPD(2012)3 cited
- → Use of a new dry powder inhaler to deliver umeclidinium/vilanterol in the treatment of COPD(2013)2 cited
- → Effect of the once-daily long-acting bronchodilator combination umeclidinium/vilanterol (UMEC/VI) and bronchodilator monotherapy on dyspnoea as measured by the transitional dyspnoea index (TDI) in COPD(2014)2 cited